JP#WUXI RC2608A(58314.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
JP#WUXI RC2608A
58314.HK
News
View More

02:00 ET HanchorBio and WuXi Biologics Enter Strategic Partnership to Advance Next-Generation Bi-and Multi-Functional Fusion Protein Pipeline

HanchorBio, Inc. has entered a strategic partnership with WuXi Biologics to advance its next-generation bi- and multi-functional fusion protein pipeline. The collaboration will leverage WuXi's end-to-end biologics development and manufacturing services to enhance clinical translation and manufacturing efficiency. This partnership aims to accelerate the development of HanchorBio's innovative fusion proteins, supporting its proprietary Fc-Based Designer Biologics (FBDB™) platform. Both companies emphasize the importance of execution speed and scalability in bringing transformative therapies to patients worldwide.

prnewswire·
US
WXXWY
-1.25%
HK
02269
+0.47%
prnewswire·
US
WXXWY
-1.25%
HK
02269
+0.47%

Hong Kong Stock Movement: INSILICO approved by FDA but fell 11.58%, leading stocks in the life sciences sector under pressure

INSILICO fell 11.58%; Jingtao Holdings fell 6.23%, with a transaction volume of HKD 792 million; WuXi Biologics fell 3.36%, with a transaction volume of HKD 442 million; WuXi AppTec fell 0.96%, with a transaction volume of HKD 323 million; WuXi Huilian fell 3.71%, with a market value of HKD 83.2 billion

HK Stock Movers Tracker·
HK
03696
-1.65%
HK
02228
-1.11%
HK
02269
+0.47%
HK Stock Movers Tracker·
HK
03696
-1.65%
HK
02228
-1.11%
HK
02269
+0.47%

Morgan Stanley's long position in Wuxi Biologics (Cayman) decreases to 2.11% on Jan 20 from 5.58%, HKEX shows

Morgan Stanley's long position in Wuxi Biologics (Cayman) decreases to 2.11% on Jan 20 from 5.58%, HKEX shows

marketscreener·
HK
02269
+0.47%
marketscreener·
HK
02269
+0.47%

Hong Kong Equities Edge Up After Recent Declines

Hong Kong stocks rose 32 points (0.1%) to 26,518, breaking a four-session losing streak, influenced by stronger U.S. futures. The rebound was led by tech and consumer sectors, reflecting gains in mainland markets after the People's Bank of China maintained lending rates. However, investor caution persisted ahead of upcoming inflation data and business confidence readings. Notable early movers included Wuxi Biologics (2.6%), SMIC (2.5%), Zijin Mining (2.2%), and China Hongqiao Group (1.9%).

Trading Economics·
US
WXXWY
-1.25%
HK
02269
+0.47%
Trading Economics·
US
WXXWY
-1.25%
HK
02269
+0.47%

Top 5 HK Stock Gainers/Losers (>100B) (1.19)

CHINA EAST AIR(00670) rose 9.2%, with a trading turnover 216.5 Million HKD, and a year-to-date rose 6.9%. CTG DUTY-FREE(01880) rose 6.65%, with a trading turnover 350.2 Million HKD, and a year-to-date rose 10.8%. MINIMAX-WP(00100) fell 13.7%, with a trading turnover 649.0 Million HKD, and a year-to-date rose 129.1%. BILIBILI-W(09626) fell 6.85%, with a trading turnover 1.7 Billion HKD, and a year-to-date rose 25.6%.

Top Gainers & Losers·
HK
00670
-5.69%
HK
01880
-0.50%
HK
03986
+7.23%
Top Gainers & Losers·
HK
00670
-5.69%
HK
01880
-0.50%
HK
03986
+7.23%
Posts
View More
© 2026 Longbridge｜Disclaimer